These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31415981)

  • 21. Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening.
    Atatreh N; Al Rawashdah S; Al Neyadi SS; Abuhamdah SM; Ghattas MA
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1373-1379. PubMed ID: 31347933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and synthesis of benzodiazepine-1,2,3-triazole hybrid derivatives as selective butyrylcholinesterase inhibitors.
    Mehrazar M; Hassankalhori M; Toolabi M; Goli F; Moghimi S; Nadri H; Bukhari SNA; Firoozpour L; Foroumadi A
    Mol Divers; 2020 Nov; 24(4):997-1013. PubMed ID: 31845210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of aryl-urea-benzofuranylthiazoles hybrids as multitasking agents in Alzheimer's disease.
    Kurt BZ; Gazioglu I; Basile L; Sonmez F; Ginex T; Kucukislamoglu M; Guccione S
    Eur J Med Chem; 2015 Sep; 102():80-92. PubMed ID: 26244990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In silico studies, nitric oxide, and cholinesterases inhibition activities of pyrazole and pyrazoline analogs of diarylpentanoids.
    Mohd Faudzi SM; Leong SW; Auwal FA; Abas F; Wai LK; Ahmad S; Tham CL; Shaari K; Lajis NH; Yamin BM
    Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000161. PubMed ID: 32886410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Mutahir S; Jończyk J; Bajda M; Khan IU; Khan MA; Ullah N; Ashraf M; Qurat-ul-Ain ; Riaz S; Hussain S; Yar M
    Bioorg Chem; 2016 Feb; 64():13-20. PubMed ID: 26595185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors.
    Bajda M; Łątka K; Hebda M; Jończyk J; Malawska B
    Bioorg Chem; 2018 Aug; 78():29-38. PubMed ID: 29529519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
    Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of multifunctional anti-Alzheimer's agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and γ-aminobutyric acid transporters.
    Pasieka A; Panek D; Jończyk J; Godyń J; Szałaj N; Latacz G; Tabor J; Mezeiova E; Chantegreil F; Dias J; Knez D; Lu J; Pi R; Korabecny J; Brazzolotto X; Gobec S; Höfner G; Wanner K; Więckowska A; Malawska B
    Eur J Med Chem; 2021 Jun; 218():113397. PubMed ID: 33838585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into (S)-rivastigmine inhibition of butyrylcholinesterase (BuChE): Molecular docking and saturation transfer difference NMR (STD-NMR).
    Bacalhau P; San Juan AA; Goth A; Caldeira AT; Martins R; Burke AJ
    Bioorg Chem; 2016 Aug; 67():105-9. PubMed ID: 27317888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling.
    Feng B; Li X; Xia J; Wu S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):968-977. PubMed ID: 28718678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.
    Shaik JB; Palaka BK; Penumala M; Eadlapalli S; Darla Mark M; Ampasala DR; Vadde R; Amooru Gangaiah D
    Chem Biol Drug Des; 2016 Jul; 88(1):43-53. PubMed ID: 26833890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of 3-(4-aminophenyl)-coumarin derivatives as potential anti-Alzheimer's disease agents.
    Hu YH; Yang J; Zhang Y; Liu KC; Liu T; Sun J; Wang XJ
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1083-1092. PubMed ID: 31117844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological activity of 1H-indene-2-carboxamides as multi-targeted anti-Alzheimer agents.
    Koca M; Yerdelen KO; Anil B; Kasap Z; Sevindik H; Ozyurek I; Gunesacar G; Turkaydin K
    J Enzyme Inhib Med Chem; 2016; 31(sup2):13-23. PubMed ID: 27226239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.
    Kamal MA; Shakil S; Nawaz MS; Yu QS; Tweedie D; Tan Y; Qu X; Greig NH
    CNS Neurol Disord Drug Targets; 2017; 16(7):820-827. PubMed ID: 28176640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1,3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors.
    Xi M; Feng C; Du K; Lv W; Du C; Shen R; Sun H
    Bioorg Med Chem Lett; 2022 Apr; 61():128602. PubMed ID: 35124202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid discovery of a selective butyrylcholinesterase inhibitor using structure-based virtual screening.
    Miles JA; Kapure JS; Deora GS; Courageux C; Igert A; Dias J; McGeary RP; Brazzolotto X; Ross BP
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127609. PubMed ID: 33039562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.